DILIC
RPRX icon

Dai-ichi Life Insurance Company’s Royalty Pharma RPRX Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.19M Sell
129,074
-24,173
-16% -$1.06M 0.18% 123
2025
Q4 		$5.92M Sell
153,247
-40,627
-21% -$1.55M 0.15% 144
2025
Q3 		$6.84M Buy
193,874
+31,996
+20% +$1.16M 0.17% 133
2025
Q2 		$5.83M Sell
161,878
-22,463
-12% -$744K 0.16% 136
2025
Q1 		$5.74M Sell
184,341
-52,115
-22% -$1.65M 0.17% 130
2024
Q4 		$6.03M Buy
236,456
+67,186
+40% +$1.78M 0.17% 137
2024
Q3 		$4.79M Buy
169,270
+75,204
+80% +$2.08M 0.12% 167
2024
Q2 		$2.48M Buy
+94,066
New +$2.61M 0.06% 263

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return